Loading...
Metabolic consequences of oncogenic IDH mutations
Specific point mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) occur in a variety of cancers, including acute myeloid leukemia (AML), low-grade gliomas, and chondrosarcomas. These mutations inactivate wild-type enzymatic activity and convey neomorphic function to produce D-2-hydroxyglu...
Na minha lista:
| Udgivet i: | Pharmacol Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4489982/ https://ncbi.nlm.nih.gov/pubmed/25956465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2015.05.003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|